Indefinite Delivery Contract 36E79726D0021
Award Date 6/15/26
Last Date to Order 6/14/27
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Exelan Pharmaceuticals Inc., headquartered in Boca Raton, Florida, was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center for the supply of Zonisamide Capsules. The contract, awarded on June 15, 2021, carries a ceiling value of $8,974,952.04 and encompasses a base performance period from June 15, 2021 through June 14, 2022, with four one-year option periods extending through June 14, 2026. The contract was issued without...
- Exelan Pharmaceuticals Inc., headquartered in Boca Raton, Florida, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency on February 1, 2023, with a contract ceiling value of $28.2 million and an ultimate completion date of January 31, 2028. This firm-fixed-price, requirements-type contract was established without a set-aside designation, allowing full and open competition. The contract originated from a Defense Logistics Agency pre-solicitation announcement...
- GSA issued the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract to Exelan Pharmaceuticals Inc. on September 15, 2020, with a contract ceiling of $3,077,719,680 and ultimate completion date of September 14, 2026. This is a multiple-award schedule catalog vehicle under which federal agencies place delivery orders for pharmaceutical products and services rather than conducting individual competitions. Exelan Pharmaceuticals, a foreign-owned pharmaceutical manufacturer and...
- Exelan Pharmaceuticals Inc. was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on September 7, 2025, for the supply of Tamsulosin Hydrochloride 0.4 milligram capsules to multiple federal healthcare systems. The contract carries a ceiling value of $88.2 million and covers a one-year ordering period from September 7, 2025, through September 6, 2026, with four additional one-year option periods exercisable at the government's...
- The Department of Veterans Affairs National Acquisition Center issued a single-award Indefinite Delivery Contract to Exelan Pharmaceuticals Inc. for the supply of Bumetanide Tablets, effective May 30, 2026, through May 29, 2027, with four one-year option periods and a ceiling value of $5,595,064.40. This unrestricted, non-set-aside procurement was conducted as a commercial item acquisition under Federal Acquisition Regulation Part 12 and represents a firm-fixed-price, requirements-type vehicle...
- Exelan Pharmaceuticals Inc. was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center to supply oseltamivir phosphate capsules and suspension on behalf of the Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The contract, valued at $10.16 million with a ceiling cap, was awarded on February 22, 2024, and includes a one-year base period (February 22, 2024 through February 21, 2025) with four...
- Exelan Pharmaceuticals Inc. was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on February 12, 2022, for the supply of lisinopril tablets across 23 different strengths and package sizes. The contract carries a ceiling value of $40.48 million with a base period of performance from February 12, 2022, through February 11, 2023, followed by four one-year option periods extending the ultimate completion date to February 11,...
- Exelan Pharmaceuticals Inc. was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center on March 17, 2024, for the supply of Escitalopram Oxalate Tablets in multiple strengths (5mg, 10mg, and 20mg). The contract carries a ceiling value of $48.4 million and establishes a base performance period from March 17, 2024, through March 16, 2025, with four one-year option periods extending through March 16, 2027. The contract was awarded...
- This Indefinite Delivery Contract (IDC) with a ceiling value of $5,592,523.40 was awarded by the Defense Logistics Agency (DLA) to Exelan Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company based in Boca Raton, Florida. The contract, which has a period of performance through June 7, 2026, is for the manufacture and distribution of various pharmaceutical products, including generic medications such as ibuprofen, citalopram, oseltamivir phosphate, and alfuzosin HCl. Exelan...
- Exelan Pharmaceuticals Inc. was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs National Acquisition Center for the supply of Metoprolol Tartrate Tablets to multiple federal healthcare systems. The contract, awarded May 8, 2026, carries a ceiling value of $13.95 million and establishes an initial one-year base period (May 8, 2026 through May 7, 2027) with four one-year option periods, providing potential contract continuity through May 2031. The...